We're sorry but your browser is not supported by Marsh.com

For the best experience, please upgrade to a supported browser:


Research and Briefings

Webcast Replay: COVID-19 - Understanding Liability Immunity Under the PREP Act


As the novel coronavirus continues its march around the globe, many businesses have ventured into new operations to assist with the battle against COVID-19. While the Department of Health and Human Services’ PREP Act declaration is intended to provide liability immunity for activities related to medical countermeasures against the ongoing pandemic, there are many questions about the extent of the legal protections provided:

  • Who qualifies as a "covered person?"
  • What is a “covered countermeasure?”
  • What are the limitations on immunity?
  • How does the PREP ACT differ from the Defense Production Act?

These questions and more were addressed during our webcast, “COVID-19: Understanding Liability Immunity Under the PREP Act.” Download the replay to hear our panel discuss the intricacies of the act along with recommendations on how to best protect your organization as it takes on new risks.


Daniel Aronson, US Casualty Leader, Marsh

Jeffrey F. Peck, Partner, Ulmer & Berne LLP

Darlene C. Villoresi, Life Sciences Casualty Leader, Marsh